Humana (HUM) Stock Value Rose While Stock Yards Bank & Trust Co Has Trimmed by $704,700 Its Position; Alphaone Investment Services Trimmed Stake in Supernus Pharmaceuticals (SUPN) as Shares Rose

January 14, 2018 - By Louis Casey

Alphaone Investment Services Llc decreased its stake in Supernus Pharmaceuticals Inc (SUPN) by 24.15% based on its latest 2017Q3 regulatory filing with the SEC. Alphaone Investment Services Llc sold 53,125 shares as the company’s stock rose 29.12% with the market. The institutional investor held 166,812 shares of the health care company at the end of 2017Q3, valued at $6.67M, down from 219,937 at the end of the previous reported quarter. Alphaone Investment Services Llc who had been investing in Supernus Pharmaceuticals Inc for a number of months, seems to be less bullish one the $2.26 billion market cap company. The stock decreased 1.34% or $0.6 during the last trading session, reaching $44.15. About 468,765 shares traded or 0.52% up from the average. Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has risen 91.80% since January 14, 2017 and is uptrending. It has outperformed by 75.10% the S&P500.

Sharlyn C. Heslam decreased its stake in Humana Inc (HUM) by 29.79% based on its latest 2017Q3 regulatory filing with the SEC. Stock Yards Bank & Trust Co sold 2,900 shares as the company’s stock rose 11.38% with the market. The hedge fund run by Sharlyn C. Heslam held 6,834 shares of the medical specialities company at the end of 2017Q3, valued at $1.67 million, down from 9,734 at the end of the previous reported quarter. Stock Yards Bank & Trust Co who had been investing in Humana Inc for a number of months, seems to be less bullish one the $37.41 billion market cap company. The stock increased 1.06% or $2.81 during the last trading session, reaching $268.02. About 1.57 million shares traded or 28.21% up from the average. Humana Inc. (NYSE:HUM) has risen 35.38% since January 14, 2017 and is uptrending. It has outperformed by 18.68% the S&P500.

Stock Yards Bank & Trust Co, which manages about $853.26 million US Long portfolio, upped its stake in Visa Inc (NYSE:V) by 9,142 shares to 192,993 shares, valued at $20.31 million in 2017Q3, according to the filing. It also increased its holding in Blackrock Inc (NYSE:BLK) by 1,487 shares in the quarter, for a total of 40,835 shares, and has risen its stake in Abbott Laboratories (NYSE:ABT).

Since August 10, 2017, it had 0 insider buys, and 7 sales for $16.22 million activity. $340,034 worth of Humana Inc. (NYSE:HUM) shares were sold by Huval Timothy S.. $3.02 million worth of Humana Inc. (NYSE:HUM) was sold by BROUSSARD BRUCE D on Friday, August 11. Shares for $1.75M were sold by BILNEY JODY L on Friday, December 15. Fleming William Kevin had sold 3,071 shares worth $770,760. Bierbower Elizabeth D sold $2.53 million worth of Humana Inc. (NYSE:HUM) on Friday, September 1.

Analysts await Humana Inc. (NYSE:HUM) to report earnings on February, 14. They expect $2.00 earnings per share, down 4.31% or $0.09 from last year’s $2.09 per share. HUM’s profit will be $279.15M for 33.50 P/E if the $2.00 EPS becomes a reality. After $3.39 actual earnings per share reported by Humana Inc. for the previous quarter, Wall Street now forecasts -41.00% negative EPS growth.

Investors sentiment increased to 1.21 in Q3 2017. Its up 0.01, from 1.2 in 2017Q2. It improved, as 44 investors sold HUM shares while 184 reduced holdings. 76 funds opened positions while 201 raised stakes. 131.39 million shares or 2.57% less from 134.86 million shares in 2017Q2 were reported. Park Natl Oh has invested 0.01% in Humana Inc. (NYSE:HUM). 6,400 are owned by Factory Mutual Insur. Parkside Bancshares And Trust holds 94 shares or 0.01% of its portfolio. Delta Asset Ltd Liability Tn, a Tennessee-based fund reported 8 shares. Caprock Grp Inc Inc invested in 1,169 shares or 0.06% of the stock. Tokio Marine Asset Mgmt Com Ltd holds 0.3% or 8,246 shares. Cullen Frost Bankers has invested 0.01% of its portfolio in Humana Inc. (NYSE:HUM). Fred Alger Inc holds 297,500 shares or 0.34% of its portfolio. Integral Derivatives Ltd Llc reported 0.01% of its portfolio in Humana Inc. (NYSE:HUM). Motco stated it has 0% in Humana Inc. (NYSE:HUM). Westpac Banking Corporation accumulated 37,141 shares or 0.2% of the stock. Capital Guardian Trust, California-based fund reported 160,065 shares. Moreover, Exxonmobil Inv Mgmt Tx has 0.16% invested in Humana Inc. (NYSE:HUM) for 26,391 shares. Clinton Gru invested in 50,781 shares. Highbridge Cap Mgmt Ltd Llc has 87,570 shares.

Among 23 analysts covering Humana (NYSE:HUM), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Humana had 67 analyst reports since July 30, 2015 according to SRatingsIntel. The company was maintained on Friday, July 22 by RBC Capital Markets. Cantor Fitzgerald downgraded the stock to “Hold” rating in Wednesday, December 7 report. The firm earned “Buy” rating on Wednesday, August 2 by Oppenheimer. As per Friday, November 3, the company rating was initiated by Credit Suisse. On Friday, October 13 the stock rating was maintained by Jefferies with “Hold”. The rating was maintained by Deutsche Bank on Monday, August 7 with “Hold”. The stock of Humana Inc. (NYSE:HUM) earned “Buy” rating by Jefferies on Friday, January 12. The firm has “Overweight” rating by JP Morgan given on Wednesday, September 16. Jefferies maintained the shares of HUM in report on Thursday, August 4 with “Buy” rating. The rating was downgraded by Cantor Fitzgerald to “Neutral” on Tuesday, April 11.

Analysts await Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) to report earnings on February, 27. They expect $0.26 EPS, 0.00% or $0.00 from last year’s $0.26 per share. SUPN’s profit will be $13.33M for 42.45 P/E if the $0.26 EPS becomes a reality. After $0.29 actual EPS reported by Supernus Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -10.34% negative EPS growth.

Since August 16, 2017, it had 0 buys, and 6 sales for $10.06 million activity. 3,709 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) shares with value of $167,755 were sold by Bhatt Padmanabh P.. Schwabe Stefan K.F. had sold 95,000 shares worth $4.43M on Thursday, September 7. PATRICK GREGORY S also sold $2.38 million worth of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) on Thursday, September 7.

Among 10 analysts covering Supernus Pharmaceuticals (NASDAQ:SUPN), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Supernus Pharmaceuticals had 35 analyst reports since August 26, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Tuesday, September 5 with “Buy”. On Monday, July 17 the stock rating was maintained by Stifel Nicolaus with “Buy”. The company was maintained on Thursday, August 3 by Piper Jaffray. The firm has “Hold” rating by Stifel Nicolaus given on Friday, October 20. The stock of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) earned “Buy” rating by FBR Capital on Wednesday, October 18. The stock of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has “Neutral” rating given on Monday, July 17 by PiperJaffray. The rating was downgraded by Piper Jaffray on Monday, July 18 to “Neutral”. Cantor Fitzgerald maintained it with “Buy” rating and $50.0 target in Monday, November 6 report. Cowen & Co maintained the stock with “Buy” rating in Monday, October 23 report. Jefferies maintained Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) rating on Thursday, August 4. Jefferies has “Buy” rating and $28 target.

Investors sentiment decreased to 0.98 in Q3 2017. Its down 0.34, from 1.32 in 2017Q2. It turned negative, as 22 investors sold SUPN shares while 97 reduced holdings. 42 funds opened positions while 75 raised stakes. 48.75 million shares or 3.64% more from 47.04 million shares in 2017Q2 were reported. Swiss National Bank has 0% invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Numeric Investors Ltd holds 51,900 shares. Quantbot Technology LP stated it has 6,208 shares or 0.02% of all its holdings. Utd Financial Advisers Ltd Llc owns 47,052 shares for 0.02% of their portfolio. Employees Retirement Of Texas has 48,000 shares. Invesco Ltd has invested 0.03% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Perigon Wealth Mngmt Limited Liability Corporation owns 1,674 shares or 0.02% of their US portfolio. Proshare Advsrs Limited Liability has 0.01% invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Rice Hall James And Assocs Limited Liability has 1.22M shares. Price T Rowe Md holds 0% or 672,681 shares. Aperio Gp Inc Lc holds 12,571 shares or 0% of its portfolio. 605,920 are owned by Emerald Advisers Pa. Creative Planning, a Kansas-based fund reported 25,034 shares. Northpointe Capital Limited Liability reported 1.07% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Oak Ridge Llc reported 0.28% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN).

Alphaone Investment Services Llc, which manages about $491.59 million and $376.30 million US Long portfolio, upped its stake in Pinnacle Finl Partners Inc (NASDAQ:PNFP) by 10,900 shares to 56,160 shares, valued at $3.76M in 2017Q3, according to the filing. It also increased its holding in Healthstream Inc (NASDAQ:HSTM) by 35,550 shares in the quarter, for a total of 207,995 shares, and has risen its stake in Financial Instns Inc (NASDAQ:FISI).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>